X.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Other Income Expense Net

Other Income/Expense Net for XTLB.

Quarterly Other Income/Expense

$427000.00

↑ 342.61% YoY

As of Dec 31, 2024

Annual Other Income/Expense (TTM)

$1.01M

↑ 195.13% YoY

Trailing 12 months ending Dec 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin